Understand stocks. Recognize innovation. Seize opportunities.

Inside Umbrella

Companies at a Glance

Current companies featured in the UMBRELLA Strategy—with insights into business models, developments, and risks.

Active icon
Bayer
Healthcare
Germany

Stock: Bayer AG

Bayer is operationally improving its earnings position. However, high debt, weak cash flow, and legal risks are slowing the stock's
Active icon
Eli Lilly
Healthcare
USA

Stock: Eli Lilly and Company

Eli Lilly is one of the leading pharmaceutical companies worldwide. Growth drivers include Mounjaro, Zepbound, and a strong pipeline in
Active icon
Revolution Medicines
Healthcare
USA

Stock: Revolution Medicines

Revolution Medicines is one of the most exciting biotech stocks for 2026. Strong Phase 3 data and a leading RAS
Active icon
Bayer
Healthcare
Germany

Stock: Bayer AG

Bayer is operationally improving its earnings position. However, high debt, weak cash flow, and legal risks are slowing the stock's
Active icon
AbbVie
Healthcare
USA

Stock: AbbVie

AbbVie is one of the leading pharmaceutical companies worldwide. Skyrizi and Rinvoq are driving growth, while patent expirations and competitive
Active icon
Palantir
Technology
USA

Stock: Palantir Technologies

Palantir impressed in Q2 2026 with strong growth, record margins, and a technical breakout.

Umbrella

Strategy

The Umbrella Strategy briefly explained

“Flexible like an umbrella” describes the core idea behind the UMBRELLA strategy.

The UMBRELLA strategy was developed to assess stocks through various market phases—regardless of whether markets are rising, falling, or moving sideways.

Strategic Allocation

Long-term oriented positioning based on macro trends, industry development, and fundamental data.

Tactical Adjustment

Short-term optimization through ongoing market monitoring, news flow, and technical chart signals.

The goal of the UMBRELLA strategy

Identifying risks and seizing opportunities. The decision-making basis is a continuous process influenced by geopolitical developments, sector analyses, company data, market sentiment, and technical analysis.

A key aspect is continuous adaptation and adjustment

“Change is the only constant”—factors such as political events, sector rotations, company news, market sentiment, and chart patterns are taken into account.

Updates play an important role in this:

They reflect new insights from research and market observation, ensuring that individual decisions can be made based on the most current information. This requires ongoing re-evaluation. The UMBRELLA strategy is an active, learning, and adaptable model for forming one’s own opinion.

Target Audience: Readers interested in capital markets

The content and contextual assessments on mumak are therefore primarily aimed at readers interested in capital markets and those with expert knowledge who wish to delve deeper into market mechanisms, investment strategies, and economic correlations.

“Flexible like an umbrella” describes the core idea behind the UMBRELLA strategy.

The UMBRELLA strategy was developed to assess stocks through various market phases—regardless of whether markets are rising, falling, or moving sideways.

Read more

Strategic Allocation

Long-term oriented positioning based on macro trends, industry development, and fundamental data.

Tactical Adjustment

Short-term optimization through ongoing market monitoring, news flow, and technical chart signals.

The goal of the UMBRELLA strategy

Identifying risks and seizing opportunities. The decision-making basis is a continuous process, influenced by geopolitical developments, sector analyses, company data, market sentiment, and technical analysis.

A key aspect is continuous adaptation and adjustment

"Change is the only constant"– factors such as political events, sector rotations, company news, market sentiment, and chart patterns–are taken into account.

Updates play an important role in this:

They reflect new insights from research and market observation, helping ensure that individual decisions can be made on the basis of the most current information available. This requires continuous re-evaluation. The UMBRELLA strategy is an active, learning, and adaptable model for forming your own opinion.

Target Audience: Readers interested in capital markets

The content and assessments on mumak are therefore primarily aimed at readers interested in capital markets as well as expert readers who want to engage in depth with market mechanisms, investment strategies, and economic interrelationships.

Discover the UMBRELLA strategy

Learn more about the strategy, our analysis method, and current research articles.

Latest MUMAK updates

Current company news, market overviews, and developments of the UMBRELLA strategy.

Weekly Update

Weekly Market Overview – November 2–November 8, 2026

A massive sell-off in US markets, exceptional quarterly results in healthcare, and extensive risk reductions: the UMBRELLA strategy responds to
Company Update

Revolution Medicines – Q3 2026 Earnings Update

RASONQUE launch brings first revenues, research expenses remain high.
Company Update

Rheinmetall – Q3 2026 Earnings Update

Strong Q3 2026, stock under pressure after guidance cut.

Research insights

Company valuations using the MUMAK method – from geopolitics and industry developments to fundamental data, market sentiment, and technical analysis.

Valuation analyses · Sector analyses · Earnings analyses · Company analyses
ALL RESEARCH INSIGHTS
Alphabet
Technology

Valuation Analysis: Alphabet

ISIN: US02079K3059

Alphabet was newly added to the UMBRELLA Strategy on September 18, 2026. Strong revenue growth, increasing operating profitability, and the dynamic development of Google Cloud are met with constructive technical analysis and positive analyst sentiment. The valuation analysis examines fundamentals, AI potential, valuation, regulation, and technical signals.
Active icon
Eli Lilly
Healthcare

Valuation Analysis: Eli Lilly and Company

Active icon
More research
Palantir
Technology

Valuation Analysis: Palantir Technologies

Active icon
More research
Revolution Medicines
Healthcare

Valuation Analysis: Revolution Medicines

Active icon
More research

About MUMAK

Financial journalism, market analyses, and the people behind them.

What is MUMAK?

MUMAK stands for "My UMbrella Stocks" and is an online financial journal that aims to provide well-founded insights into stocks.

The goal is to make the background and approaches of the UMBRELLA strategy easy to understand. The content is meant to be explained simply, in various financial-journalistic ways, and presented in a comprehensible manner.

MUMAK – Financial journalism with a track record.

The UMBRELLA strategy serves as a systematic approach

  • Consideration of geopolitical developments
  • Classification within sector and macro trends
  • Fundamental valuation of companies
  • Market sentiment, news analysis, analyst opinions, and social trading perspectives
  • Discussion of technical analysis

This combination aims to provide a nuanced view of opportunities and risks surrounding the stock market. This can provide a basis for individual decision-making processes.

Who is behind MUMAK

MUMAK is being built and continuously developed by Richard Dobetsberger and Lina Mosentseva.

Richard Dobetsberger

Richard Dobetsberger

Richard Dobetsberger developed the UMBRELLA strategy, a structured approach that combines geopolitical developments, fundamental data, market sentiment, and technical analysis. This combination of scientific methodology, geopolitical thinking, and capital markets practice forms the foundation.

Lina Mosentseva

Lina Mosentseva

Lina Mosentseva has spent over ten years working with stock markets, social trading, and financial analysis. She combines classic company analysis with modern digital financial communication and ensures that complex market developments are made easy to understand.

Together, they combine analytical depth with structured presentation– with the goal of making developments in the stock market comprehensible.